Here are our top ten facts about platelets that everyone needs to know: Platelets are one of the cells present in your blood. They are essential for stopping bleeding and helping blood to clot. They are produced in your bone marrow from very large bone marrow cells called megakaryocytes.
One drop of your blood contains as many as 1,,,, platelets. Platelet transfusions can help patients with some blood diseases, cancers and to help control bleeding after severe trauma and major surgery.
Hence, the lengthening of platelet lifetimes in these animals is caused by the loss of the removal system, not because the platelet surface escapes desialylation in the circulation. Once again, platelets harvested from these null mice have high levels of exposed galactose that bind the RCA I lectin avidly.
This again demonstrates the central role of the Asgr in recognizing and removing desialylated platelets. The importance of hepatocyte-platelet interaction extends beyond simple removal, as the recognition and ingestion of platelets by the Asgr generates cytoplasmic signals in hepatocytes that induce the formation and secretion of cytokines to promote marrow and megakaryocyte growth and maturation.
In this case, the key cytokine produced in response to platelet ingestion is thrombopoietin [ 16 ]. Thus, the hepatocyte-platelet interaction directly feeds back to megakaryocytes in marrow, helping to stimulate platelet production. One group includes the lectin receptors that recognize carbohydrate alterations in platelet glycoproteins.
Mannose receptors are a second example of a receptor that detects glycan alterations, recognizing underlying mannose moieties exposed by glycosylases [ 18 ]. Accelerated clearance requires either the accumulation of opsonins on the platelet surface such as Igs and complement or the presence of agents in blood that remove protective molecules.
Both types of mechanisms occur. These include congenital and drug or pathogen induced thrombocytopenia. In general, platelet clearance is primarily driven by splenic macrophages, a process that can result in splenomegaly. In many cases, patients having ITP, respond well to anti-Fc antibody treatment. Bacterial-derived sialidases, released into blood during sepsis, cause platelet counts to drop precipitously.
Animals lacking a functional Asgr do not accelerate their platelet clearance in response to sepsis. A related process accounts for the circulation failure of platelets transfused after rewarming from refrigerated storage. Resting platelets contain sialidases that are stored in an internal compartment that can be released by activation [ 15 , 20 ].
Rewarming from the cold releases a portion of the sialidase activity to the platelet surface and into the storage media, a process that mediates desialylation of the platelet surface glycoproteins. Hence, macrophages also participate in clearance. Severe thrombocytopenia TCP is also a signature component of the Wiskott-Aldrich syndrome; WAS platelets are small and have shortened circulatory lifetimes. WAS patients produce diverse autoantibodies and WAS platelets collect higher amounts of surface-associated immunoglobulins Igs than do normal platelets [ 21 ].
Unlike ITP, homologous platelets circulate normally in WAS patients strongly suggesting a more complex mechanism for removal that involves receptors other than Fc. It has been widely believed that platelet clearance is accelerated in these animals because the autoimmune aspect of the disease results in increased Igs bound to the platelets surface that led to recognition by splenic macrophages.
However, as in the human conditions, normal platelets, when transfused into WASp KO mice, circulate normally indicating that a simple anti-platelet antibody mediated clearance is not the mechanism. In mice, splenectomy has been shown to be without effect on the clearance rate. In efforts to identify the mechanism of removal, WASp Null platelets were transfused into mice lacking specific phagocytic receptors. A survey on macrophage receptors failed to reveal any in which the WASp null platelets had enhanced circulatory lifetimes.
However, WASp KO platelets were found to circulate normally in Asgr null mice, a finding once again posits the Asgr as a central molecule involved in the recognition and removal of damaged platelets.
The surface of WASp KO platelets is, however, not desialylated and lectin binding studies have instead revealed hypersialylation. This sialylation occurs specifically in the 2,6 linkage, not the normal 2,3 linkage. Critically, the Asgr also receptor recognizes this unique sialic linkage, leading to binding and platelet removal. The carrier of this sialic acid turns out to be surface bound Ig and sialylation of its Fc N-linked glycan shifts recognition of the Fc domain from macrophages to the hepatocytes.
Interestingly, the source of the 2,6 sialyltranferase ST6Gal1 is liver hepatocytes, which make and secrete this enzyme into blood. This blood enzyme is an acute phase reactant protein, upregulated in liver in response to bacterial sepsis, cancer, or inflammation. In this case, platelet ingestion itself, feedbacks to upregulate ST6Gal1 mRNA transcription and translation and this increases by fold the blood levels of this enzyme. Because WASp is a protein that interacts with the actin cytoskeleton, it is likely that internal cytoskeletal changes in its absence result in an altered topology of platelet receptors or the expression of the neo-epitope.
In general, platelet function in the absence of WASp is near normal although as the precision of assays increase, some differences have now been recognized.
Active platelets lack small focal actin assembly sites in the absence of WASp, although spreading and filopodial formation are normal. In resting platelets, failure to express WASp alters the stability of microtubules, increasing their acetylation and slowing their turnover. How these internal changes alter the surface remains for future studies.
The basic processes involved in megakaryocyte commitment, maturation and platelet formation are well described although many precise details remain to be clarified. Proplatelet and platelet production requires a massive enlargement in MK size that is driven by high levels of mRNA transcription from their amplified polyploid nuclei followed by mRNA translation into platelet essential components.
This includes the production of an abundant internal network of membranes called the demarcation membrane system DMS that dramatically increases the apparent membrane to surface ratio during proplatelet formation, platelet specific granules, and the synthesis of large amounts of the cytoskeletal machinery that is used to form and fill assembling platelets. As MKs mature, they develop an extensive network of internal membranes called the DMS that are enriched phosphatidylinositol 4,5 bisphosphate and the vWf receptor [ 22 ] and are used as the primary membrane source for proplatelet elongation.
To form the DMS, the plasma membrane of megakaryocytes enfolds at specific sites and a perinuclear pre-DMS is generated. Next, the pre-DMS is expanded into its mature form by material added from golgi-derived vesicles and endoplasmic reticulum-mediated lipid transfer.
This structural description is in accordance with the studies on platelet glycosyltransferases, which arrive early in the forming DMS and eventually make their way to the megakaryocyte and platelet surfaces [ 24 ]. Only a small number of proteins have been identified thus far to participate in the DMS formation process based on alterations in its structure in certain knockout animals.
The OCS, like the DMS, is a unique anastomosing network of internal membrane tubes that is connected to the plasma membrane at multiple points.
To release platelets, megakaryocytes in the marrow space move to and nestle the marrow sinusoids where they project their proplatelet protrusions into the blood flow [ 25 , 26 ].
He relied on blood and platelet donors to keep him alive while he waited for his transplant to take and allow his body to begin generating the healthy new stem cells, blood cells and platelets needed to keep him alive. Read more about Owen and his incredible journey here. She has a passion for motivating and educating blood donors through storytelling. I am Oneblood Testimonials Video Gallery. About Hosting Submit Hosting Form.
Promotions Search Rewards Store. Milestone Store. All blood donors must wear a mask regardless of vaccination status. They also release wound healing-associated growth factors including platelet-derived growth factor PDGF , which directs cell movement; TGF beta, which stimulates the deposition of extracellular matrix tissue into a wound during healing; and vascular endothelial growth factor VEGF , which stimulates angiogenesis, or the regrowth of blood vessels.
These growth factors play a significant role in the repair and regeneration of connective tissues. Local application of these platelet-produced healing-associated factors in increased concentrations has been used as an adjunct to wound healing for several decades. Platelets : A blood slide of platelets aggregating, or, clumping together.
The platelets are the small, bright purple fragments. If the number of platelets is too low, excessive bleeding can occur and wound healing will be impaired. However, if the number of platelets is too high, blood clots can form thrombosis , which may obstruct blood vessels and result in ischemic tissue damage caused by a stroke, myocardial infarction, pulmonary embolism, or the blockage of blood vessels to other parts of the body.
Thrombosis also occurs when blood is allowed to pool, which causes clotting factors and platelets to form a blood clot even in the absence of an injury. Platelets are membrane-bound cell fragments derived from megakaryocytes, which are produced during thrombopoiesis. Platelets are small, clear, irregularly-shaped cell fragments produced by larger precursor cells called megakaryocytes.
Platelets are also called thrombocytes because they are involved in the blood clotting process, which is necessary for wound healing. Platelets are continuously produced as a component product of hematopoiesis blood cell formation. Platelets are produced during hematopoiesis in a sub-process called thromopoiesis, or production of thrombocytes.
Thrombopoiesis occurs from common myeloid progenitor cells in the bone marrow, which differentiate into promegakaryocytes and then into megakaryocytes. Megakaryocytes stay in the bone marrow and are thought to produce protoplatelets within their cytoplasm, which are released in cytoplasmic extensions upon cytokine stimulus. The protoplatelets then break up into hundreds of platelets that circulate throughout the bloodstream, while the remaining nucleus of the ruptured megakaryocyte is consumed by macrophages.
Megakaryocyte and platelet production is regulated by thrombopoietin, a hormone produced by the liver and kidneys. Thrombopoietin stimulates differentiation of myeloid progenitor cells into megakaryocytes and causes the release of platelets.
0コメント